skip to main | skip to sidebar

The Health, Drug, Prescription, and GMP Supersite

Thoughts and resources about health, drugs and prescriptions, and how they are affected by GMPs (FDA Good Manufacturing Practices) and other regulations.

Sunday, June 7, 2020

COVID-19 - How To Protect Yourself And Others - CDC.gov

The pandemic is not over yet!


The CDC tells us:

How to Protect Yourself & Others



Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
Designated Rep Certification Class
CA Designated Representative Training Program
California Designated Representative Training Program
California HMDR Exemptee Training
Exemptee Certification Class
FL CDR Exam Prep
SkillsPlus Intl Inc. - The Leader in Compliance Training
The Health, Drug, Prescription, and GMP Supersite Gift Store 

Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted by Austin Lee at 5:57 AM
Labels: cdc, COVID, guidelines, recommendations

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

From SkillsPlus International Inc.

Loading...
  • Home
  • SkillsPlus Intl Inc - The Leader in QSR & GMP Training
  • Popular FDA, cGMP, QSR, & GMP Training Courses
  • The Best Exemptee & Designated Representative Training Courses - Online Self-Study
  • CA HMDR Exemptee Certification Class
  • California Exemptee Certification - State Approved
  • The Exemptee Institute
  • The Designated Representative Institute
  • SkillsPlus Intl Inc Blog
  • Home Medical Device Retail - California HMDR Exemptee Training Certification Course
  • Designated Representative Online Training Courses

California Designated Representative Training


Designated Representative Wholesaler Training Course

Designated Representative 3PL Training Course

Designated Representative Reverse Distributor Course

SkillsPlus International Inc. is the ONLY training provider approved by the California State Board of Pharmacy to offer California Designated Representative training programs for wholesalers, 3PL, and reverse distributors. Nearly 10,000 students have taken our state license-related training courses! #2025 #2026 #2027

CA Designated Rep 3PL Course

CA Designated Rep 3PL Course
California Designated Representative 3PL Online Training Course. #2025

The Best Exemptee Training



Sign-up for Exemptee training now!


California HMDR Exemptee license online training certification class for home medical device retailers. Earns a course completion certificate accepted by the California Department of Public Health - Food and Drug Branch. We've added something new, closed captioning. Students can read what the course instructor is teaching. Nearly 10,000 students have taken our state license-related training courses! This feature helps ESL (English as a second language) students, and hard of hearing students. #2025 #2026 #2027

CGMP Online Training Courses

CGMP Online Training Courses
Current Good Manufacturing Practice Training: A New Generation Series - CGMP Online Courses

GMP Trainer Courses

GMP Trainer Courses
GMP Trainer Awareness, Certification, and Master Trainer Courses

Root Cause Analysis - cGMP Training

Root Cause Analysis - cGMP Training
cGMP Training - Online Self-Study Course - Root Cause - Investigation Reports

Subscribe To

Posts
Atom
Posts
Comments
Atom
Comments
Subscribe to The Health, Drug, Prescription, and GMP Supersite by Email

Blog List

  • Marler Blog
    ByHeart Cronobacter Recall 2022 and FDA Warning Letter 2023 predates Botulism Outbreak 2025
    2 hours ago
  • eLearning Industry
    From Training To Transformation: What It Takes To Make Learning Stick
    2 hours ago
  • Wellness Blog - NY Times
    Infant Formula Recalled Amid Botulism Investigation
    4 hours ago
  • Food Poison Journal
    13 babies with Botulism linked to Infant Formula
    21 hours ago
  • CNBC Health Care
    Trump tells Senate Republicans to send federal health insurance money 'directly to the people'
    1 day ago
  • Government Executive
    ​​​​​​​Shutdown fight in the Senate likely to drag through the weekend
    1 day ago
  • BioPharma Dive - Latest News
    Pfizer wins bidding war for Metsera with $10B offer
    1 day ago
  • BioPharma Dive
    Pfizer wins bidding war for Metsera with $10B offer
    1 day ago
  • FierceBiotech
    Pfizer beats out Novo with $10B agreement to buy Metsera
    1 day ago
  • All Kaiser Health News
    Journalists Shed Light on Opioid Settlement Cash, New Medicaid Work Requirements
    1 day ago
  • Medtech Insight
    Synchron Secures $200M Series D, Plans New Brain Interface With ‘Potentially More Applications’
    1 day ago
  • Pharmaceutical Commerce
    2 days ago
  • GEN Biotech News
    PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China
    2 days ago
  • FDA What's New: Drugs
    Fresenius Kabi Issues Voluntary Nationwide Recall of Three Lots of Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL Fill in a 2 mL Vial Due to Out-of-Specification Endotoxin Results in Certain Reserve Samples
    2 days ago
  • Pharmalot – STAT
    STAT+: Up and down the ladder: The latest comings and goings
    2 days ago
  • FierceBiotech: Medtech
    Organon divests Jada System, sends 100 employees to Laborie Medical Technologies in $465M deal
    2 days ago
  • Medscape Today Headlines
    Rediscovering Purpose in the Hardest Moments of Cancer Care
    2 days ago
  • Healthcare Packaging
    Through the Line Podcast: Automatic Capsule Filling Machine Ramps Up Production
    2 days ago
  • FiercePharma
    J&J brings 'invisible illness' IBD out of the shadows with report supporting the power of patient community
    2 days ago
  • NPR Blogs: Shots - Health News Blog
    Under RFK Jr., the CDC is scrutinizing the childhood vaccine schedule
    2 days ago
  • Pharmafile
    Vesper Bio reports positive topline results for dementia candidate
    2 days ago
  • Drug & Device Law
    OTC Preemption Letdown in the Eastern District of Pennsylvania
    2 days ago
  • Science-Based Medicine
    Dr. Vinay Prasad Rose to Power by “Calling For” His Predecessors to do Things. How’s He Doing Now That He’s Had a Chance to Prove His Mettle?
    2 days ago
  • Drug Channels
    Hubs, AI, and the New Era of Revenue Protection in Patient Access
    2 days ago
  • FDA - Press Releases
    FDA Awards Second Batch of National Priority Vouchers
    3 days ago
  • Quality Matters
    Working Collaboratively for a Quality and Resilient Supply Chain: Conversation with AAM’s John Murphy at GRx + Biosims 2025
    3 days ago
  • Clarkston Consulting
    From Static to Dynamic: Reimagining Inventory Allocation in Real Time
    3 days ago
  • 33 Charts
    The AI coding arms race
    6 days ago
  • Ted Eytan, MD
    Virgin Voyages Valiant Lady
    6 days ago
  • JD Supra Law News
    The Pitch - October 2025
    6 days ago
  • World Pharma - Breaking News
    New switch for programmed cell death identified
    6 days ago
  • The Incidental Economist
    Trump’s Prescription Drug Policy: Rhetoric vs. True Reform
    1 week ago
  • Clinical Correlations
    The Original Bird Flu: Chlamydia psittaci
    1 week ago
  • Pharmafile - Mfg & Production
    Sharp invests $100m in US and EU manufacturing and packaging facilities
    1 week ago
  • The Compliance and Ethics Blog
    Why Compliance Is the Cornerstone of Ethical Medical Billing
    3 weeks ago
  • Asbestos and Mesothelioma News
    What the Court Documents Show About J&J’s $966M Loss
    3 weeks ago
  • FDA - Health Fraud
    BIG GUYS Male Energy Supplement contains hidden drug ingredient
    3 months ago
  • Mobihealthnews
    Mendaera gets FDA 510(k) clearance for handheld robotic system
    4 months ago
  • SkillsPlus International Info
    FDA Rushed Out AI Tool
    5 months ago
  • The Health, Drug, Prescription, and GMP Supersite
    Designated Representative Training - California | State-Approved
    5 months ago
  • Modern Healthcare News
    Meet the Administration for a Healthy America, HHS' newest agency
    5 months ago
  • Designated Representative and Exemptee
    Designated Representative Training | Board-Approved Courses | Recommended
    7 months ago
  • Pharma IQ Regulatory-Legal
    AI-Driven Productivity Gains: Transforming Pharma Supply Chain Efficiency
    8 months ago
  • FDA – Policy & Medicine
    FDA Releases Draft Guidance on the Accelerated Approval Process
    8 months ago
  • BioPharma-Reporter RSS
    Inhibikase to pause development of Parkinson’s drug
    9 months ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    9 months ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    9 months ago
  • Biotech Blog
    Making Medicines Affordable: The Role of Generics
    10 months ago
  • BioSpace Regulatory News
    FDA Questions Strength of Evidence Backing Zevra’s Rare Disease Therapy Ahead of Adcomm
    1 year ago
  • Healthy Travel Blog
    Hello world!
    1 year ago
  • Quality Digest - FDA Compliance
    Nine Strategies for Effective Internal Audits
    1 year ago
  • Eye on FDA
    FDA Adds New AdComm to Address Genetic Metabolic Diseases
    1 year ago
  • Designated Representative Training Courses
    The Only Board-Approved California Designated Representative Training Programs For ...
    1 year ago
  • HMDR Exemptee Online Training
    California HMDR Exemptee Online Training Certification Course
    1 year ago
  • Medgadget
    Plant-Based Soft Medical Robots
    1 year ago
  • Drug Injury Watch
    Ozempic / Wegovy: Stomach And Intestinal Problems Can Be Irreversible, Life-threatening
    2 years ago
  • Golf Foodie
    More women in the U.S. are drinking themselves to death, research finds
    2 years ago
  • PharmaPhorum News
    Patient adherence – the key to restoring trust in pharma
    2 years ago
  • Pharma Manufacturing
    How pharma can overcome inflation
    3 years ago
  • Pharmaceutical Industry | Processing & Engineering: Knowledge, News and Analysis | Pharmaceutical Manufacturing
    How pharma can overcome inflation
    3 years ago
  • CA Designated Rep Training
    Recommended! California Designated Representative Online Training Courses
    6 years ago
Show 5 Show All

Blog Archive

  • ►  2025 (1)
    • ►  June (1)
  • ►  2024 (5)
    • ►  August (1)
    • ►  July (1)
    • ►  May (1)
    • ►  March (2)
  • ►  2023 (6)
    • ►  December (1)
    • ►  October (2)
    • ►  July (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2022 (26)
    • ►  November (3)
    • ►  October (1)
    • ►  August (2)
    • ►  July (3)
    • ►  June (4)
    • ►  May (3)
    • ►  April (3)
    • ►  March (1)
    • ►  February (3)
    • ►  January (3)
  • ►  2021 (17)
    • ►  December (2)
    • ►  November (2)
    • ►  October (2)
    • ►  September (2)
    • ►  July (1)
    • ►  April (1)
    • ►  March (1)
    • ►  February (2)
    • ►  January (4)
  • ▼  2020 (27)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (4)
    • ►  August (2)
    • ►  July (2)
    • ▼  June (2)
      • California Designated Representative Training Cour...
      • COVID-19 - How To Protect Yourself And Others - CD...
    • ►  May (1)
    • ►  April (1)
    • ►  March (2)
    • ►  February (5)
  • ►  2019 (28)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (2)
    • ►  August (3)
    • ►  July (6)
    • ►  June (3)
    • ►  May (2)
    • ►  April (1)
    • ►  February (3)
  • ►  2018 (6)
    • ►  October (1)
    • ►  August (1)
    • ►  July (1)
    • ►  June (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2017 (14)
    • ►  November (1)
    • ►  October (2)
    • ►  August (1)
    • ►  July (1)
    • ►  May (2)
    • ►  April (1)
    • ►  March (1)
    • ►  January (5)
  • ►  2016 (32)
    • ►  December (6)
    • ►  November (4)
    • ►  October (2)
    • ►  September (2)
    • ►  August (2)
    • ►  July (3)
    • ►  June (1)
    • ►  May (3)
    • ►  March (4)
    • ►  February (2)
    • ►  January (3)
  • ►  2015 (68)
    • ►  December (2)
    • ►  November (7)
    • ►  October (10)
    • ►  September (5)
    • ►  August (1)
    • ►  July (6)
    • ►  June (7)
    • ►  May (5)
    • ►  April (3)
    • ►  March (3)
    • ►  February (13)
    • ►  January (6)
  • ►  2014 (105)
    • ►  December (10)
    • ►  November (9)
    • ►  October (1)
    • ►  September (9)
    • ►  August (4)
    • ►  July (6)
    • ►  June (11)
    • ►  May (10)
    • ►  April (10)
    • ►  March (11)
    • ►  February (15)
    • ►  January (9)
  • ►  2013 (127)
    • ►  December (7)
    • ►  November (14)
    • ►  October (7)
    • ►  September (11)
    • ►  August (7)
    • ►  July (9)
    • ►  June (9)
    • ►  May (6)
    • ►  April (8)
    • ►  March (22)
    • ►  February (9)
    • ►  January (18)
  • ►  2012 (172)
    • ►  December (8)
    • ►  November (20)
    • ►  October (10)
    • ►  September (8)
    • ►  August (4)
    • ►  July (22)
    • ►  June (23)
    • ►  May (17)
    • ►  April (17)
    • ►  March (12)
    • ►  February (13)
    • ►  January (18)
  • ►  2011 (116)
    • ►  December (8)
    • ►  November (15)
    • ►  October (4)
    • ►  September (18)
    • ►  August (9)
    • ►  July (6)
    • ►  June (8)
    • ►  May (9)
    • ►  April (5)
    • ►  March (13)
    • ►  February (10)
    • ►  January (11)
  • ►  2010 (106)
    • ►  December (14)
    • ►  November (8)
    • ►  October (5)
    • ►  September (6)
    • ►  August (10)
    • ►  July (5)
    • ►  June (9)
    • ►  May (11)
    • ►  April (5)
    • ►  March (11)
    • ►  February (10)
    • ►  January (12)
  • ►  2009 (192)
    • ►  December (11)
    • ►  November (11)
    • ►  October (15)
    • ►  September (13)
    • ►  August (10)
    • ►  July (19)
    • ►  June (16)
    • ►  May (16)
    • ►  April (17)
    • ►  March (16)
    • ►  February (19)
    • ►  January (29)
  • ►  2008 (245)
    • ►  December (32)
    • ►  November (39)
    • ►  October (39)
    • ►  September (33)
    • ►  August (52)
    • ►  July (50)

Disclaimer & Privacy Policy

All data and information provided on this site is for informational purposes only. Drughealth.blogspot.com makes no representations as to accuracy, completeness, currentness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages arising from its display or use. All information is provided on an as-is basis. We use third-party advertising companies to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, click here.

SkillsPlus International Inc.

SkillsPlus International Inc.
SkillsPlus International Inc. Logo